April 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


BCRP and OCRP Pre-Announcements for 2017

***Updated to include PCRP and LCRP***
To be Announced See Links Below Federal Breast/Ovarian

CDMRP
Breast Cancer Research Program (BCRP)
Ovarian Cancer Research Program (OCRP)
Prostate Cancer Research Program (PCRP) &
Lung Cancer Research Program (LCRP)
FY17 Pre-announcements

Descriptions of the initiatives planned for these programs can be found at the links below.  The pre-announcements allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
Contact: Office of Sponsored Research (x6804)
Program Links: Breast Cancer Research Program  
Ovarian Cancer Research Program
Prostate Cancer Research Program
Lung Cancer Research Program


Reminder
Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

 
Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Letters of intent are accepted year round; full applications are by invitation only.
Amount & Project Period: Gateway funds research studies with a budget estimate in the range of $200,000-$800,000.  1 - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Grant Application Process

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03
September 30, 2017 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1

NEW
See Below Postdocs Non-federal Poster/Travel Awards - Lymphatic

Lymphatic Education & Research Network
Lymphatic Forum 2017 Travel and Poster Awards

LE&RN is proud to co-host and sponsor Lymphatic Forum 2017 in Chicago, June 8-10, 2017.  Over 30 internationally renowned scientists will come together to discuss research in basic and disease-oriented areas of lymphatic and vascular biology including therapeutic approaches
Due Dates: See website
Amount & Project Period: Travel Awards:  $500 to defray costs of attendance at the Lymphatic Forum 2017-Exploring the Lymphatic Continuum. Best Poster Presentation Awards:  one for $1,000 and three for $500.
Eligibility: Young investigators who are LE&RN Supporting Members (PhD students, medical students and postdocs).
Links: Travel & Poster Awards
Various NCI

NEW
Multiple See Below Federal Cancer Moonshot℠

Cancer Moonshot℠ - Funding Opportunities

NCI has identified funding opportunity announcements (FOAs) from within its extensive research portfolio that address the goals of the Cancer Moonshot.   This portfolio will expand over the next 7 years.  Planning for implementation of longer-term scientific initiatives is underway.  Multiple ways to fund the best science, including grants, supplements and other mechanisms are being considered.
Due Dates: Multiple - See specific FOA
Amount & Project Period: See specific FOA
Eligibility: See specific FOA
Contact: Office of Sponsored Research (x6804)
RFA Link: Overview Ι Cancer Moonshot℠  Funding Opportunities






March 22 (LOI) See Below Non-federal Pancreatic

SU2C-Lustgarten Foundation Pancreatic Cancer Interception Dream Team

 Prioritized areas of interest include both applied and fundamental research including: discovery and implementation of innovative methods that effectively detect pancreatic cancer at an early and surgically curable stage; new tools for monitoring disease progression and therapeutic response, which could potentially serve as surrogate endpoints for clinical trials and regulatory approval; investigation of novel chemoprevention or immune prevention approaches; development of risk prognostication methods for pre-invasive pancreatic neoplasms and other conditions that elucidate molecular details underlying that increased risk; understanding of immune suppression and inflammation mechanisms that promote pancreatic cancer and design of methods to circumvent this; and more generally research targeted at generating sufficient knowledge to justify a clinical intervention to test novel hypotheses related to early detection and treatment of pancreatic cancer.
Due Dates: Mar. 22 (Letter of Intent)
Invited Submissions:  June 22 (OSR) June 26 (Sponsor)
Amount & Project Period: $7M - 4 years (All funding is contingent upon milestones and objectives being appropriately selected and satisfactorily pursued and achieved.)
Eligibility: Must include laboratory and clinical researchers, senior and young investigators, and senior scientists who have not necessarily worked together in the past;
Each Team will consist of a Dream Team Leader, a Dream Team Co-leader, no more than 4 addnl. Dream Team Principals, and at least 2 Advocates, w/a minimum of 3 participating institutions See Dream Team Eligibility Criteria in Guidelines for additional requirements.
Contact: Office of Sponsored Research (x6804)
Link: proposalCentral (RFA located at this site which is also   submission site.)
Admin. Supplement NIH
NCI is a participating Institute
March 30 See Below Federal Career Development

Research Supplements to Promote Diversity in Health-Related Research

The supplements to promote diversity will provide funding to recruit and support students, postdocs, and eligible investigators from groups that have been shown to be underrepresented in health-related research.
Due Dates: NCI accepts applications through March 30th.  Submissions are to be made to OSR no later than 48 hours prior to the planned submission date. 
Applications will be accepted for a second round from October 1 - December 1, 2017.
Amount & Project Period: Varies with level of candidate;
Salary support and addnl. funds for supplies & travel vary depending on level of candidate.
Eligibility: Parent grant must have at least 2 years support remaining;
An R01 or R01-equivalent grant may support no more than 2 Diversity Supplement candidates;
An R21 or R21-equivalent grant may support no more than 1 Diversity Supplement candidate whose career level is graduate student or more junior;
Must be citizens or non-citizen nationals of the U.S. or have been lawfully admitted for permanent residence in the U.S.
Graduate student and postdocs receiving support from an agency of the Public Health Service (PHS) at time of submission are not eligible
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-288 (Research Supplements to Promote Diversity in Health-Related Research)
NCI Diversity Supplement Guidelines
Admin. Supplement NIH
NCI is a participating Institute
March 30 See Below Federal Career Development

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers  

 The purpose of the supplement is to support individuals with high potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances. Provides supplemental funds to existing NIH research grants for the purpose of supporting full-time or part-time research by these individuals to update their existing research skills and knowledge.
Due Dates: NCI accepts applications through March 30th.  Submissions are to be made to OSR no later than 48 hours prior to the planned submission date. 
Applications will be accepted for a second round from October 1 - December 1, 2017.
Amount & Project Period: Postdoctoral fellows:  salary not to exceed $50,000/yr. Supplies/travel: up to $6,000/yr. w/justification.
Investigators developing independent research careers: salary consistent w/institutional policy and w/level of support provided by an NCI CDA, but not to exceed $100,000/yr. Supplies and travel: up to $10,000/yr., w/justification.
Eligibility: Parent grant must have at least 2 years support remaining;
See NCI Guidelines for candidate eligibility requirements
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-289
NCI Re-Entry Supplements Guidelines (Please note that the guidelines still has the old Program Announcement link, but that is to be updated.)




March 31 All Ranks Federal Health Equity

Department of Health & Human Services
Office of Minority Health
Partnerships to Achieve Health Equity

The purpose of the Partnership program is to demonstrate that multi-partner collaborations that address social determinants of health and have a nationwide or regional reach, focus or impact can efficiently and effectively do one of the following: (1) improve access to and utilization of care by racial and ethnic minority and/or disadvantaged populations; (2) develop innovative models for managing multiple chronic conditions; (3) increase the diversity of the health workforce; or (4) increase data availability and utilization of data that increases the knowledge base regarding health disparities and facilitates the development, implementation and assessment of health equity activities.
Due Dates: Mar 29 (OSR) | Mar. 31 (Sponsor)
Technical Assistance Webinar:  February 22, 2017 at 3:00-4:00 pm ET - Register 
Additional Technical Assistance Webinar: "Evaluation - Review the Basics":  February 23, 2017 at 3:00-4:30 pm ET - Register  
Amount & Project Period: $325,000-$400,000/yr. - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link:  MP-CPI-17-001


March 31 See below Non-federal Career Development

American Society for Radiation Oncology

Due Dates: Mar. 29 (OSR) Ι Mar. 31 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: proposalCENTRAL
 

2017 Junior Faculty Career Research Training Award

ASTRO funds research in radiation biology, cancer biology and radiation physics. Funding opportunities are available for junior faculty and residents.   The Junior Faculty award is for faculty in early stages of their career to explore opportunities in research.  It provides an opportunity to have focused time for research projects in radiation oncology, biology or physics and provides funds to generate pilot data that can be used for future federal funding applications.
Amount & Project Period: $200,000 - 2 years
Eligibility: Board-eligible physician or physicist in radiation oncology or a radiobiologist w/in first 5 years of junior faculty appt.;
Candidate and at least one mentor must be active ASTRO members;
At least 50% effort required for this award
Link: Overview
 

Residents/Fellows in Radiation Oncology Seed Grant

This grant is designed to support residents or fellows who are planning a career focusing primarily on basic science or clinical research.  Specific areas of interest may include but are not limited to: 1. Basic and clinical research in the radiation therapy sciences. 2. Projects in which innovative techniques, new methods or special equipment leading to better patient care are developed. 3. Aspects of health care planning and delivery, including outcome evaluation studies (i.e., health services research-related activities). 4. Development of programs in health education relevant to the radiation therapy sciences.
Amount & Project Period: $25,000 - 1 year
Eligibility: Candidate and at least one mentor must be active ASTRO members;
At least 75% effort required for this award
Link: Overview


Semi-annual Due Date
April 01 See Below Non-federal Career Development

American Cancer Society
Career Development Awards

The first of 2 annual deadlines for career development awards in a process where scientists propose projects that they believe are ready to be tackled with the available knowledge and techniques.
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: proposalCENTRAL |  ACS Grant Types
Postdoctoral Fellowships
Amount & Project Period: $48,000, $50,000, and $52,000 per year - 3 years
$4,000/yr. fellowship allowance.
Eligibility: Must be U.S. citizen or permanent resident of U.S. at application.
Mentored Research Scholar Grant
Amount & Project Period: $135,000/yr. (Direct Costs) - 5 years
Eligibility: Be w/in first 4 years of initial full-time faculty position 
Research Scholar Grants
Amount & Project Period: $165,000/yr. (Direct Costs) - 4 years
Eligibility: Must currently have an independent research or faculty position
April 01 All Faculty Ranks Non-federal Palliative Care

Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

To support clinician investigators conducting patient-oriented research in palliative care, applications are solicited for pilot/exploratory research grants in palliative care of cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator's chances of competing successfully for larger grants.
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor)
Amount & Project Period: $60,000/yr. (Direct Costs) - 1 to 2 years
Eligibility: All Faculty Ranks - Must hold a full-time faculty position or equiv. in U.S.
Contact: Office of Sponsored Research (x6804)
Links: RFA Ι proposalCENTRAL (Submission Site)

April 01 All Ranks Non-federal Myeloproliferative Neoplasms

The MPN Research Foundation
2017 MPN Challenge
A Grant Program supported by the MPN Research Foundation and the Leukemia & Lymphoma Society  

The objective is to change the trajectory and ultimate prognosis for patients with myeloproliferative neoplasms (MPNs), including MF, PV and ET.  This program represents an important partnership between MPNRF and LLS, who share a mission to advance the scientific understanding of MPNs and bring new treatments and the hope for a cure to patients with these rare diseases.
Due Dates: Mar 30 (OSR) Ι Apr. 01 (via email to Sponsor)
Amount & Project Period: $200,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: 2017 Request for Research Proposals


April 01 Postdocs Non-federal Career Development

Cancer Research Institute
Irvington Postdoctoral Fellowship Program

 Candidate must be working in areas directly related to cancer immunology.  Eligible projects fall into the broad field of immunology and must show relevance to solving the cancer problem. Proposals that do not encompass both these areas will not be considered.
Due Dates: Mar 30 (OSR) Ι Apr. 01 (Sponsor)
Additional 2017 Due Date:  Oct. 01
Amount & Project Period: 3 years
Annual Stipend:  $55,000, $57,000 & $59,000
Institutional Allowance:  $1,500/yr.
Eligibility: Must have doctoral degree by award activation;
Must have less than 5 years postdoc experience;
Must have less than 3 years' experience in sponsor lab at award activation
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines


NEW
April 05 (LOI) Faculty Non-federal Drug Discovery

Harrington Discovery Institute
2018 Scholar-Innovator Program

This program supports efforts to advance promising drug discoveries. Applications must have a focus that includes fundamental discovery (elucidation of novel targets and leads) or development of new drugs or biologics or drug-device combinations.
Due Dates: Apr. 05 (Letter of Intent)
Invited Applications:  May 29 (OSR) Ι May 31 (Sponsor)
Amount & Project Period: $100,000 guaranteed; opportunity to qualify for $700,000 - milestone based over 2 years Pharmaceutical industry drug development expertise and project support through Harrington Discovery Institute's Innovation Support Center
Eligibility: Physician-scientists w/MD or MD/PhD Project may have only one Principal Investigator (PI)
Contact: Office of Sponsored Research (x6804)
Link: Award Program Details
UG3/UH3 NCI

April 09 (LOI) All Ranks Federal Quantitative Imaging

Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment

This FOA seeks applications addressing development, optimization and validation of quantitative imaging (QI) software tools and methods for prediction and/or measurement of response to cancer therapies or for planning and validating radiation therapy treatment strategies in clinical trials.   The initial UG3 exploratory phase is to be used for the development and optimization of QI tools and methods chosen for study by the investigating team, while the UH3 phase is for the clinical validation of the tools/methods developed in the UG3 phase.
Due Dates: Apr. 09 (Letter of Intent)
May 05 (OSR) Ι May 09 (Sponsor)
Additional 2017 Due Date:  September 12th
Amount & Project Period: $300,000/yr. (Direct Costs UG3 phase) - 2 years
$500,000/yr. (Direct Costs UH3 phase) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-128
Companion FOA: PAR-17-129 (U01)
R01 NIH

NEW
April 13 (LOI) All Ranks Federal Native American Populations

Interventions for Health Promotion and Disease prevention in Native American Populations

The purpose of this funding opportunity announcement (FOA) is to develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations. The NCI is interested in applications focusing on both individual and community interventions relating to primary and secondary (screening) cancer prevention. It is important that researchers consider the context in which people live (place, built environment, etc.) and develop interventions that can improve overall health and result in improved health outcomes as they relate to cancer and cancer survivorship.
Due Dates: Apr. 13 (Letter of Intent)
Applications Due: May 10 (OSR) Ι May 12 (Sponsor)
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-14-260
Admin. Supplement NCI

Mechanisms eligible for supplement: R21, R33, U01, & U24

              

 
April 13 All Ranks Federal Technology Collaborations

Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research

To accelerate the development of new enabling cancer technologies, the NCI invites requests for supplemental funding to support and encourage new multidisciplinary scientific collaborations among awardees from the Innovative Molecular Analysis Technologies (IMAT) program which supports highly innovative, data-generating platforms and methodologies and the Informatics Technologies for Cancer Research (ITCR) program which supports powerful data processing and visualization technologies.
Due Dates: Apr. 10 (OSR)|Apr. 12 (Sponsor)
Additional 2017 Due Dates: Jul. 25th & Dec. 12th
Amount & Project Period: Limited to $50,000/yr. (Direct Costs) per parent award.  Project and budget periods must be w/in currently approved project period for existing parent award.
Eligibility: Individual(s) must hold an active grant or cooperative agreement as noted in left column
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-143


April 13, 4:00pm, EST All Ranks Non-federal Drug Discovery

Sanford Burnham Prebys Medical Discovery Institute
Florida Translational Research Program

The Program provides Florida-based scientists with access to experienced professionals and state-of-the-art technological resources for drug discovery to facilitate an interdisciplinary, collaborative approach to establish a pipeline of potential new treatments for today's most challenging and unmet medical needs.
Due Dates: Apr. 13, 4:00pm (EST)
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: FTRP Projects


NEW
RESTRICTED SUBMISSION
April 14 Junior Faculty Non-federal Career Development

The V Foundation for Cancer Research
V Scholar Grant – Restricted Submission

 This is an opportunity for young tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research.
This is a restricted submission and Moffitt will have the opportunity to submit two applications. One of the two nominee applicants  must identify as someone from an underrepresented in science minority ethnic group  for the purposes of this application are defined as African American or people of African descent, Hispanic-American, or  Native American and Alaskan Native.
Due Dates: Pre-applications are due by April 14, 2017 via email to Maureen.Ahearn@moffitt.org  Pre-applications will be reviewed internally by REX.  The Pre-application must include a 1 page letter of introduction and a 2-page outline and be submitted electronically in PDF format only.  The final submission to the V-Foundation will be June 1, 2017.
Amount & Project Period: $200,000 - 2 years
Eligibility: By the Due Date of Application, applicants must have all the following:
Hold a tenure-track faculty position as an assistant professor at their cancer research institution;
Appointed to first full-time assistant professor position w/in last 5 years, and not yet been promoted to Associate Professor; Clinical scientists are eligible if the research institution can demonstrate that it will fully support the research applicant (e.g., dedicated lab space, start-up funds, dedicated research time).
Applicant must be either US Citizen or be a permanent legal resident in U.S.
Applicant can NOT already have been awarded an RO1 or RO1-equivalent grants.
Contact: Maureen Ahearn (x8824) for additional information and guidelines.


Semi-annual Due Date
April 14 Junior Faculty Non-federal Career Development

American Cancer Society Institutional Research Grant (ACS-IRG)
ACS-IRG Pilot Projects Funding Opportunity

Pilot funding opportunities to support junior faculty in initiating cancer-related research projects that assist them in competing successfully for national research grants.
Due Dates: April 14 (OSR) Proposals are to be submitted to OSR for review 2 days prior to the published due date.  OSR will forward proposals prior to deadline.  USF and Ponce investigators are to submit proposals directly to Maureen.Ahearn@moffitt.org
Amount & Project Period: $30,000 - 1 year
Eligibility: Full-time faculty members at the Assistant Member/Assistant Professor level or equiv.;
PI must have no active peer-reviewed funding at time of submission or award.
Recipients of active state and nationally competitive grants (e.g. R01, VA Merit, FIRST R29 or Bankhead Coley) are not eligible. However, holders of career development grants such as NIH K- series or the ACS's Junior Faculty and Junior Clinical Research Awards are eligible as long as they meet all other criteria and proposed project does not duplicate other funded work. Previous awardees of an R21, R01 or equiv. are not eligible. Must be independent and have an institutional commitment for salary and space;
Must be w/in first six years of initial faculty appointment. In the case of Ponce investigators, must be w/in the first 6 years of a faculty research appointment.
Research Scientists are eligible to apply; must be independent and w/in 2 years of a tenure-track appointment. A letter of support from the Department Chair supporting the expectation of a tenure-earning position is required.
PI must be a Permanent Resident of the U.S. and must submit notarized evidence indicating Resident Alien Card or “Green Card”, I-551, or approval for the issuance of such card as evidenced by an official passport stamp of the U.S. Immigration Service or a form I-797.
Contact: Maureen Ahearn (x8824)
Links: ACS-IRG Spring Guidelines  Ι  ACS-IRG Spring Application


April 14 Postdocs/Early-stage Clinicians Non-federal Career Development

William Guy Forbeck Research Foundation
Scholar Award

Scholars have the unique opportunity to attend the Annual Forbeck Forum, a 3-day retreat in Lake Geneva, Wisconsin for four consecutive years   The Forum topic this year is MYC and RAS.  The key objectives of the Scholar Retreat are:
     Expedite current research
     Bridge the gap between institutions and scientific specializations
     Share issues relating to the career path of a young investigator
Additional benefits of being a Forbeck Scholar include the opportunity to host a Focus Meeting and apply for research funding through the Collaborative Research Program.
Due Dates: Apr. 14 (Submit application to lauren@wgfrf.org or
admin@wgfrf.org)
Amount & Project Period: Scholars will participate in four sequential retreats, with all expenses paid by WGFRF.
Eligibility: Scholars may include post-doctoral fellows and clinicians in the early phases of their career.
Contact: Lauren Roadman, Administrator,  lauren@wgfrf.org
Links: WGFRF Scientific Activities Ι Scholars


NEW
April 15 All Ranks Non-federal Patient Safety Education

The Doctors Company Foundation
Patient Safety Research

The purpose is to support patient safety education for healthcare professionals in training and in practice, and patient safety research with clinically useful applications. In this context, patient safety is defined as a healthcare discipline that minimizes the incidence and impact of adverse events by redesigning systems and processes using human factors principles to reduce errors.
Due Dates: Apr. 13 (OSR) Ι Apr. 15 (Sponsor)
Amount & Project Period: No amount specified - 1 to 3 years (Funding from this organization is limited so applications should reflect a realistic timeframe and budgets should be reasonable in accordance with proposed objectives.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Grant Application Process

NEW
April 20 (LOI) All Ranks Federal Clinical Effectiveness

Patient Centered Outcomes Research Institute (PCORI)
Pipeline to Proposal Awards Tier A Pre-Engagement/Community Projects

The purpose of the Pipeline to Proposal (P2P) Awards program is to help people form new collaborations with the goal of developing proposals for research with sound scientific rigor and robust patient engagement.  We are interested in research teams that include patients, caregivers, clinicians, and other healthcare stakeholders, as well as researchers.  The P2P program now has two tiers. The first (Tier A) is designed to support the development of research partnerships as they identify a comparative clinical effectiveness research (CER) question (or series of questions) that is important to patients, researchers, and other members of the healthcare community.
Due Dates: Apr. 20 (Letter of Intent)
Amount & Project Period: $50,000 -1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Key Information Ι Application Guidelines
R21 NIH
NCI is a participating Institute
April 23 (LOI) All Ranks Federal Liver

Mechanisms of Disparities in Chronic Liver Diseases and Cancer

The purpose of the initiative is to support multidisciplinary research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the US.
Due Dates: Apr. 23 (Letter of Intent)
May 18 (OSR) Ι May 22 (Sponsor)
Additional Due Dates: Apr. 4, 2018, Apr. 4, 2019
Amount & Project Period: $275,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-150
Companion FOA: PAR-17-151 (R01)

April 24 All Faculty Ranks Non-federal Prostate

Prostate Cancer Foundation
2017 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer

Awards are for investigations of metastatic, lethal prostate cancer. Awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired.
Due Dates: Apr. 20 (OSR) Ι Apr. 24 (Sponsor)
Online application submission portal live at https://pcf.smartsimple.com as of  Friday, February 10th)
Amount & Project Period: $1 million per team - 2 years
Eligibility: Team should be composed of at least 3 highly experienced investigators and may be assembled from one or more institutions;
Team must include at least one young investigator as an integral contributor. (Young investigator may be Postdoc, Instructor, Research Associate, Asst. Professor, or equiv. and sh/be w/in 6 years of completing a professional degree or clinical training, and have received <$200,000 in current direct research funding from all sources including institutional funds.)
Contact: Office of Sponsored Research (x6804)
Links: RFA | Challenge Awards
U01 NCI


April 25 (LOI) All Ranks Federal Screening

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

Applications are encouraged that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, colorectal, cervical and lung cancers.  Appropriate applications should propose to intervene at one or more levels, and must measure outcomes at three or more levels, while accounting for interactions that occur between levels.
Due Dates: Apr. 25 (Letter of Intent)
May 24 (OSR) Ι May 26 (Sponsor)
Amount & Project Period: It is anticipated and encouraged that requests be in the range of $400,000 to $500,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-146
U01 NCI

April 27 (LOI) All Ranks  Federal Care Delivery

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

This FOA seeks to advance the science of multilevel interventions in 3 ways: a) by establishing a common conceptualization of levels and associated level-specific factors that affect practice; b) by standardizing metrics of the levels and their main effects on other levels and the individuals needing follow-up care; and c) by developing and standardizing analysis of the effect of interventions on individuals, groups, and organizations responsible for intervention implementation. This FOA also encourages applications that test interventions to improve the follow-up of abnormal screening in one or more ways, including: a) measuring multilevel effects of single-level interventions; b) comparing single vs. multilevel interventions; and c) testing multilevel interventions.
Due Dates: Apr. 27 (Letter of Intent)
May 24 (OSR) Ι May 26 (Sponsor)
Additional Due Date:  Sept.  21st
Amount & Project Period: $450,000 - $500,000/yr. (Direct Costs) Note:  Larger budgets may be requested but no request may exceed $750,000/yr. (Direct Costs) - 4 years
Eligibility: All Ranks - Multiple PD/PI applications could have different responsibilities w/respect to one or more of the following: 1) analysis and metrics, 2) medical care interventions, & 3) behavioral interventions.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-108
R01 NCI

NEW
April 30 (LOI) All Ranks Federal Imaging

Perception and Cognition Research to Inform Cancer Image Interpretation

This FOA facilitates research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis.
Due Dates: Apr. 30 (Letter of Intent)
Applications Due:  May 25 (OSR) Ι May 30 (Sponsor)
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-125
Companion FOA: PAR-17-124 (R21)


April 30 All Ranks Non-federal Research Projects

Elsa U. Pardee Foundation
Research Grants

The Foundation funds research directed toward identifying new treatments or cures for cancer, and particularly encourages applications  allowing establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers.  Project relevance to cancer detection, treatment, or cure should be clearly identified.
Due Dates: Apr. 27 (OSR) Ι Apr. 30 (Sponsor)
Additional 2017 Due Date:  Aug. 31st
Amount & Project Period: No limits stated; must be reasonably & clearly supported by scope of project in application - 1 year suggested
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Grant Application Process
R01 NCI

April 30 (LOI) All Ranks Federal Imaging

Perception and Cognition Research to Inform Cancer Image Interpretation  

The purpose is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis.
Due Dates: Apr. 30 (Letter of Intent)
May 25 (OSR) Ι May 30 (Sponsor)
Additional 2017 Due Date:  September 26th
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact:  Office of Sponsored Research (x6804)
FOA Link: PAR-17-125
Companion FOA: PAR-17-124 (R21)
R01 NIAID

May 07 All Ranks Federal Natural Killer (NK) Cells

NK Cells to Induce Immunological Memory to Prevent HIV Infection

The purpose is to support multidisciplinary, hypothesis-driven research on Natural Killer (NK) cells, leading to the discovery of pathways relevant for early immune responses and immune regulation impacting the potential protective immunity to be induced by HIV vaccination.
Due Dates: May 04 (OSR) Ι May 07 (Sponsor)
Additional Due Dates:  Standard Aids Dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-114
U01 NCI

NEW
May 10 (LOI) All Ranks Federal Glycomics

Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories

Through this FOA, the NCI encourages research projects to elucidate how changes in cellular carbohydrates may promote cancer initiation and progression and use this information to identify glycan-based abnormalities to serve as biomarkers for early cancer detection or risk assessment. 
Due Dates: May 10 (Letter of Intent)
Applications Due:  June 06 (OSR) Ι June 08 (Sponsor)
Amount & Project Period: Anticipated and encouraged are requests up to a maximum of $500,000/year (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-206
Companion FOA: PAR-17-207, U01
R01 NIH

NEW
May 19 (LOI) All Ranks Federal Head & Neck

Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers

The purpose of this FOA is to support basic and preclinical research aimed at developing novel immunotherapeutic targets for head and neck cancers (HNC), including salivary gland cancers. Research will identify human HNC-specific neoantigens, and will test the utility of these neoantigens as targets for eliciting anti-tumor immune responses in affected patient populations.
Due Dates: May 19 (Letter of Intent)
Applications Due:  June 15 (OSR) Ι June 19 (Sponsor)
Amount & Project Period: Limited to $350,000 in direct costs - 5  years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-DE-18-004


NEW
May 19 (Initial Proposal) All Faculty Ranks Non-federal MDS

The Taub Foundation
Grants Program for MDS Research

This program supports high-impact, innovative, translational research to understand the underlying causes of MDS and to advance its treatment and prevention. Innovative studies with transformative potential to elucidate MDS etiology and to develop new treatments are particularly encouraged.
Due Dates: Initial Proposal: May 17 (OSR) Ι May 19 12:00 Noon, EDT 
                                                         (Sponsor)
Invited Submissions:  Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: $600,000 - 3 years
Eligibility: All Faculty Ranks
U.S. citizenship not required; no visa documentation required
Contact: Office of Sponsored Research (x6804)
Link: Application Materials
R21 NIH

NEW
May 30 (LOI) All Ranks Federal NCI Provocative Questions

Research Answers to NCI's Provocative Questions

The purpose is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative.  Each application must address one and only one specific PQ, exactly as defined in FOA.
Due Dates: May 30 (Letter of Intent)
Applications Due:  June 26 (OSR) Ι June 28 (Sponsor)
Additional 2017 Due Date:  Oct. 30
Amount & Project Period: $275,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-018 
Companion RFA: RFA-CA-17-017 (R01)

NEW
May 31 All Ranks Non-federal Ovarian

Tell Every Amazing Lady Louisa M. McGregor Ovarian Cancer Foundation
2017 T.E.A.L.® Medical Research and Awareness Program Beneficiary

   The Tell Every Amazing Lady® About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation 2017 Medical Research Program offers funding in support of ovarian cancer research studies that are most aligned with that mission as determined by the T.E.A.L.® board of directors and scientific advisory board. The mission of the T.E.A.L.® is to promote public awareness of and education about the signs, symptoms, and risk factors of ovarian cancer, provide support to survivors, and raise funds for research in order to find a cure.
Due Dates: May 29 (OSR) Ι May 31 (Sponsor)
Amount & Project Period: $60,000/year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFP
R01 NCI

NEW
May 30 (LOI) All Ranks Federal Imaging - CTs

Early Phase Clinical Trials in Imaging and Image-Guided Interventions

This FOA is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided planning and/or execution therapy, contrast kinetic modeling, 3-D reconstruction and other quantitative tools.
Due Dates: May 30 (Letter of Intent)
Applications Due:  June 26 (OSR) Ι June 28 (Sponsor)
Additional 2017 & 2018 Due Dates: Oct. 11; and Feb. 14; June 28, & Oct. 11, 2018
Amount & Project Period: $500,000 (Direct Costs) for total period.  No more than $250,000 (Direct Costs) may be requested in any single year. - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-167
S10 NIH

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)


NEW
May 31 See Below Federal Equipment

Shared Instrumentation Grant (SIG) Program

This FOA encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass and nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.
Due Dates: May 26 (OSR) Ι May 31 (Sponsor)
Amount & Project Period: Maximum award is $600,000 - 1 year
Eligibility: PD/PI should have documented (in the biographical sketch) technical expertise directly related to the type of the chosen instrument. PD/PI does not need to have an NIH research grant or any other research support, but is expected to be an expert on the requested instrument. PD/PI may be a Core director, tenured, or non-tenured faculty member of the applicant organization.  Multiple PDs/PIs are not allowed.
Three Major Users (w/active NIH research awards) having a substantial need for the instrument must be identified. Once this eligibility requirement has been met, additional users with active research awards from NIH or other sources may be added as Major or Minor Users
Contact: Office of Sponsored Research (x6804)  
FOA Link: PAR-17-074
Admin. Supplements NIH

NEW
June 01 See Below Federal Data Sharing - Cancer Epidemiology

Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies

Funds are available for administrative supplements to prepare and deposit individual-level data from cancer epidemiology studies into NCI-supported, controlled-access databases including the Cancer Epidemiology Data Repository (CEDR) and the database of Genotypes and Phenotypes (dbGaP).
Due Dates: May 30 (OSR) Ι  June 01 (Sponsor)
Amount & Project Period: $100,000 (Total Costs). Project/budget period must be w/in currently approved project period for existing parent award.  Projects must be completed within one calendar year.  Requests for no-cost extensions on parent grant to accommodate supplement are not permitted.
Eligibility: Must hold an active grant or cooperative agreement, and the research proposed in the supplement must be accomplished within the competitive segment of the active award  (P01, R01, R03, R21, U01, UM1)
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-224
R01 NIH

NEW
June 05 All Ranks Federal Screening Older Adults

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults

The purpose is to promote research on interventions, based in healthcare settings, designed to reduce overscreening for breast, cervical, or colorectal cancers among average-risk older adults. These tests may be overused, thereby subjecting adults to unnecessary risks. Research is needed both to understand the factors that drive overuse and to develop and test interventions that will reduce overuse in healthcare delivery systems.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard Dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-110
Companion FOA: PA-17-109 (R21)
R01 NIH

NEW
June 07 All Ranks Federal In vivo Cancer Imaging Systems

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems

The purpose is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status. A distinguishing feature of each application will be formation of an academic-industrial partnership, which is a strategic alliance of investigators in academic, industrial, and any other entities who work together as partners to identify and translate a technological solution or mitigation of a cancer-related problem.
Due Dates: Applications Due:  June 05 (OSR) June 07 (Sponsor)
Additional 2017 Due Date:  Oct. 03
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-093
R01 NCI

NEW
June 13 All Ranks Federal Cancer Communication

Innovative Approaches to Studying Cancer Communication in the New Media Environment

This FOA invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life.
Due Dates: June 09 (OSR) Ι June 13 (Sponsor)
Additional Due Date:  Oct. 11
Amount & Project Period: Application Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-249
Companion FOA: PAR-16-248 (R21)
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org